Login
Login
切换导航
Home
Articles
Journals
Books
News
About
Services
Submit
Home
Journal
Articles
Journals A-Z
Browse Subjects
Biomedical & Life Sci.
Business & Economics
Chemistry & Materials Sci.
Computer Sci. & Commun.
Earth & Environmental Sci.
Engineering
Medicine & Healthcare
Physics & Mathematics
Social Sci. & Humanities
Browse Subjects
Biomedical & Life Sciences
Business & Economics
Chemistry & Materials Science
Computer Science & Communications
Earth & Environmental Sciences
Engineering
Medicine & Healthcare
Physics & Mathematics
Social Sciences & Humanities
Publish with us
Paper Submission
Information for Authors
Peer-Review Resources
Open Special Issues
Open Access Statement
Frequently Asked Questions
Publish with us
Paper Submission
Information for Authors
Peer-Review Resources
Open Special Issues
Open Access Statement
Frequently Asked Questions
Follow SCIRP
Contact us
customer@scirp.org
+86 18163351462(WhatsApp)
1655362766
Paper Publishing WeChat
Complete Matching
Editorial Board
Show/Hide Options
Show/Hide Options
All
Title
Abstract
Keywords
DOI
Author
Journal
Affiliation
ISSN
Subject
Potential of a planarian model to study certain aspects of anti-Parkinsonism drugs
(Articles)
Robert B. Raffa
,
Jeff Danah
,
Christopher S. Tallarida
,
Carrie Zimmerman
,
Grace Gill
,
Steven J. Baron
,
Scott M. Rawls
Advances in Parkinson's Disease
Vol.2 No.3
,July 19, 2013
DOI:
10.4236/apd.2013.23014
7,446
Downloads
11,218
Views
Citations
Biological sources of L-DOPA: An alternative approach
(Articles)
Sushama A. Patil
,
Onkar A. Apine
,
Shripad N. Surwase
,
Jyoti P. Jadhav
Advances in Parkinson's Disease
Vol.2 No.3
,July 19, 2013
DOI:
10.4236/apd.2013.23016
20,242
Downloads
29,494
Views
Citations
Clinical Patterns of Primary Dystonias among Hospitalized Patients in Baghdad and Kut in Iraq
(Articles)
Saadoun Al Ameer
,
Samer Mohammed Saeed
,
Bahaa Hassan
,
Zaki Noah Hasan
World Journal of Neuroscience
Vol.5 No.5
,November 13, 2015
DOI:
10.4236/wjns.2015.55035
5,368
Downloads
6,087
Views
Citations
Efficacy and Safety of Nasal Administration of “Na-no-L-DOPA” Based on PLGA Nanoparticles
(Articles)
I.G. Kondrasheva
,
T.A. Antipova
,
G.G. Barsegyan
,
P.Ye. Gambaryan
,
A.A. Guseva
,
A.A. Kamensky
Engineering
Vol.4 No.10B
,January 16, 2013
DOI:
10.4236/eng.2012.410B007
3,526
Downloads
5,250
Views
Citations
Effects of L-Dopa and Dopamine D2 Agonists on Recollection and Familiarity in Idiopathic Nondementing Parkinson’s Disease
(Articles)
Nicola M. J. Edelstyn
,
Thomas A. Shepherd
,
Andrew R. Mayes
,
Susan M. Sherman
,
Simon J. Ellis
Neuroscience and Medicine
Vol.2 No.4
,December 2, 2011
DOI:
10.4236/nm.2011.24042
5,801
Downloads
9,401
Views
Citations
Pharmacological strategies for Parkinson’s disease
(Articles)
José-Rubén García-Montes
,
Alejandra Boronat-García
,
René Drucker-Colín
Health
Vol.4 No.11A
,November 29, 2012
DOI:
10.4236/health.2012.431174
7,969
Downloads
13,027
Views
Citations
This article belongs to the Special Issue on
Parkinson's Disease
Unilateral 6-OHDA
th-fgfr1
(
tk-
) mouse model supports the role of FGFs in Parkinson’s disease and the effects of nicotine and L-DOPA on spontaneous motor impairments
(Articles)
Aaron Kucinski
,
Scott Wersinger
,
Ewa K. Stachowiak
,
Milen Radell
,
Renae Hesse
,
Thomas Corso
,
Matthew Parry
,
Merouane Bencherif
,
Kristen Jordan
,
Sharon Letchworth
,
Michal K. Stachowiak
Health
Vol.4 No.11A
,November 29, 2012
DOI:
10.4236/health.2012.431176
4,877
Downloads
7,538
Views
Citations
This article belongs to the Special Issue on
Parkinson's Disease
Follow SCIRP
Contact us
customer@scirp.org
+86 18163351462(WhatsApp)
1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Home
Journals A-Z
Subject
Books
Sitemap
Contact Us
About SCIRP
Publication Fees
For Authors
Peer-Review Issues
Special Issues
News
Service
Manuscript Tracking System
Subscription
Translation & Proofreading
FAQ
Volume & Issue
Policies
Open Access
Publication Ethics
Preservation
Retraction
Privacy Policy
Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.
Top